Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota

NCT03863730 · clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
56
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Odense University Hospital

Collaborators